Lipid-lowering medications. HMG-CoA reductase inhibitors. Rosuvastatin.
Treatment of hypercholesterolemia For adults and children over 10 years of age with primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) as an adjunct to the diet when the diet and the use of other non-drug products (e.g. exercise, weight loss) are insufficient. In homozygous familial hypercholesterolemia as an adjunct to the diet and other lipid-lowering treatments (e.g., LDL apheresis) or when such treatment is inappropriate. Prevention of cardiovascular disorders Prevention of significant cardiovascular disorders in patients at high risk of the first case of cardiovascular disorders, as an adjunct to the correction of other risk factors.